Business Segments and Geographic Areas

9 Months Ended

Sep. 30, 2011

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

Business segments and geographic areas

CONMED conducts its business through five principal operating segments, CONMED Endoscopic Technologies, CONMED Endosurgery, CONMED Electrosurgery, CONMED Linvatec and CONMED Patient Care.  We believe each of our segments are similar in the nature of their products, production processes, customer base, distribution methods and regulatory environment.  Our CONMED Endosurgery, CONMED Electrosurgery and CONMED Linvatec operating segments also have similar economic characteristics and therefore qualify for aggregation.  Our CONMED Patient Care and CONMED Endoscopic Technologies operating units do not qualify for aggregation since their economic characteristics do not meet the criteria for aggregation as a result of the lower overall operating margin in these segments.

CONMED Endosurgery, CONMED Electrosurgery and CONMED Linvatec consist of a single aggregated segment comprising a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic procedures, electrosurgical generators and related surgical instruments, arthroscopic instrumentation for use in orthopedic surgery and small bone, large bone and specialty powered surgical instruments.  CONMED Patient Care product offerings include a line of vital signs and cardiac monitoring products as well as suction instruments & tubing for use in the operating room.  CONMED Endoscopic Technologies product offerings include a comprehensive line of minimally invasive endoscopic diagnostic and therapeutic instruments used in procedures which require examination of the digestive tract.

The following is net sales information by product line and reportable segment:

	Three months ended September 30,				Nine months ended September 30,
	2010		2011		2010		2011
Arthroscopy	$	68,229	$	69,384	$	215,303	$	215,449
Powered Surgical Instruments	34,645		34,790		105,404		111,081
CONMED Linvatec	102,874		104,174		320,707		326,530
CONMED Electrosurgery	23,788		23,298		70,836		72,923
CONMED Endosurgery	16,750		17,676		50,973		54,707
CONMED Linvatec, Endosurgery,
and Electrosurgery	143,412		145,148		442,516		454,160
CONMED Patient Care	16,273		15,347		50,893		48,607
CONMED Endoscopic Technologies	12,510		12,319		36,237		36,733
Total	$	172,195	$	172,814	$	529,646	$	539,500

Total assets, capital expenditures, depreciation and amortization information are impracticable to present by reportable segment because the necessary information is not available.

The following is a reconciliation between segment operating income and income before income taxes:

	Three months ended September 30,						Nine months ended September 30,
	2010			2011			2010			2011
CONMED Endosurgery, Electrosurgery and Linvatec	$	20,056		$	21,607		$	58,583		$	66,411
CONMED Patient Care	(367		)	(785		)	1,179			(2,520		)
CONMED Endoscopic Technologies	109			520			71			685
Corporate	(4,596		)	(5,402		)	(16,292		)	(14,675		)
Income from operations	15,202			15,940			43,541			49,901
Loss on early extinguishment
of debt	—			—			79			—
Amortization of debt discount	1,059			1,131			3,167			3,338
Interest expense	1,749			1,670			5,269			5,182
Income before income taxes	$	12,394		$	13,139		$	35,026		$	41,381